Efficacy of Cotrimoxazole as a De-escalation Treatment of Ventilator-Associated Pneumonia in Intensive Care Unit
Condition(s):Ventilator Associated PneumoniaLast Updated:January 29, 2024Recruiting
Hide Studies Not Open or Pending
Condition(s):Ventilator Associated PneumoniaLast Updated:January 29, 2024Recruiting
Condition(s):Idiopathic Pulmonary FibrosisLast Updated:November 14, 2017Terminated
Condition(s):TuberculosisLast Updated:September 16, 2014Completed
Condition(s):Covid19; Severe COVID-19 PatientsLast Updated:July 16, 2020Unknown status
Condition(s):Bacterial InfectionsLast Updated:September 21, 2020Completed
Condition(s):Acute Kidney InjuryLast Updated:February 2, 2022Completed
Condition(s):HIV-1-infection; Pneumocystis Pneumonia; Opportunistic Infections; Preventive Therapy; Antibiotic Side EffectLast Updated:October 2, 2019Completed
Condition(s):Acquired Immunodeficiency Syndrome; Infant, Newborn; Anemia; Neutropenia; HIV InfectionsLast Updated:February 25, 2011Completed
Condition(s):Childhood PneumoniaLast Updated:July 7, 2009Completed
Condition(s):COVID-19 PneumoniaLast Updated:May 13, 2021Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.